Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$9,231,778
+$3,649,428 QoQ
Shares Held
54,775
+29.3% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#162
of 768 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $16,464,256 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (56.1% of the industry book) .
All Filings in NBIX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,231,778 | 54,775 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,582,350 | 42,374 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,985,060 | 84,503 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,632,198 | 11,627 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,341,866 | 10,676 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,099,720 | 37,068 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,278,186 | 9,364 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,157,840 | 18,728 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,578,283 | 18,728 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,622,824 | 19,017 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,037,009 | 15,460 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,812,262 | 16,109 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,659,962 | 17,603 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,063,369 | 20,385 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,309,252 | 19,334 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,065,678 | 19,449 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||